HAHN MARK W (Chief Financial Officer) sold 1.6% of their position (208.91K shares) of VERONA PHARMA PLC on the open market
Open‑market sale worth $2.75M — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/5/2025ACC: 0001104659-25-074398
Officer· Chief Financial Officer
Since Jan 2021
-208.91K
Net shares
Net seller
$2.75M
Total sold
1
Open market trades
0B · 1S
4
Total transactions
255.70K acquired · 464.61K disposed
Non-Derivative Transactions2
Ordinary Shares
Direct
Shares
+255.70K
Price / share
—
Trade value
—
% of position
2.1%
8/1/2025
12.42M→12.67M
Ordinary Shares
Direct
Shares
−208.91K
Price / share
$13.14
Trade value
$2.75M
% of position
1.6%
8/1/2025
12.67M→12.46M
Total
Net shares
+46.78K
Net value
-$2.75M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 8/1/2025 | M · Option Exercise | +255.70K | — | — | 2.1% | 12.42M | 12.67M |
| Ordinary Shares Direct | 8/1/2025 | S · Sale | −208.91K | $13.14 | $2.75M | 1.6% | 12.67M | 12.46M |
| Total | +46.78K | -$2.75M | ||||||
Derivative Transactions2
Restricted Stock Units
Direct
Converts to
Ordinary Shares
200K shares
Shares
−200K
Strike price
Held after
800K
Exercisable
—
8/1/2025
Restricted Stock Units
Direct
Converts to
Ordinary Shares
55.70K shares
Shares
−55.70K
Strike price
Held after
389.79K
Exercisable
—
8/1/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Ordinary Shares200K shares | 8/1/2025 | M · Option Exercise | −200K | — | 800K | |
| Restricted Stock Units Direct | Ordinary Shares55.70K shares | 8/1/2025 | M · Option Exercise | −55.70K | — | 389.79K |